Responses

PDF

Clinical phenotyping of newly diagnosed type 2 diabetes in Yemen
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Bedside diagnosing T2DM from birth is the first activity in the fight against this growing epidemic.
    • Sergio Stagnaro, Director Quantum Biophysical Semeiotic Research Laboratory

    T2DM first problem still open is to recognize diabetics so far without proper diagnosis, in order to avoid the series of complications that arise decades before the clinical diabetic symptomatology decades before the clinical diabetic symptomatologyFDA Commissioner Scott Gottlieb, MD, said: "Diabetes affects nearly 30 million Americans. Access to affordable insulin is literally a matter of life and death". Aurobindo would say this is a true and false statement. Why do we all, including FDA, not radically solve the real problem underlying the diabetic growing epidemic? Let's start talking about Pre-Primary and Primary Prevention of T2DM, based on Diabetic and Dislipidemic-Dependent, Inherited Real Risk, bedside diagnosed from birth with a stethoscope, and removed by inexpensive Reconstructing Mitochodrial Quantum Therapy. The till now open problem in the traditional Accademic Medicine is the clinical diagnosis of T2DM from the First of its Five Stages. Well. Recently, a new and original reliable clinical method for diagnosing DM has been added to a flurry of methods that have existed for twenty years. The Corpus Callosum is the part of the brainthat allows communication between its two hemispheres. It is responsible for transmitting neural messages between both the right and left hemispheres. According to Angiobiopathy Theory, microvessel dynamic parallels the related parenchima cell activity. As a consequence,thanks to Quantum Biophysical Semeiotic, physi...

    Show More
    Conflict of Interest:
    None declared.